There are 8 papers on indoleamine 2,3-dioxygenase in aging research: 3 observational studies in people, 1 in animals, 4 in cells.
8 papers study it37 more mention it4 findings
1 new paper in 30 daysSee all 45 papers on indoleamine 2,3-dioxygenase
“IDO activity independently predicted MetS. In ROC curve analysis, TG/HDL-C demonstrated high (AUC = 0.886) and IDO activity moderate (AUC = 0.646) performance in predicting Mtes.”
- Humans3
- Animals1
- Cells4
Interventions
2Quercetin
no changein human cells1
1 study
Quercetin
no changein human cells1
Quercetin showed no clear effect on indoleamine 2,3-dioxygenase in human cells.
“Quercetin treatment did not, however, negatively affect adipogenesis, chondrogenesis, or indoleamine 2,3 dioxygenase secretions.”
Cells10 μM
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells
Cellular and molecular bioengineering
Dasatinib
no changein cells1
1 study
Dasatinib
no changein cells1
Dasatinib showed no clear effect on indoleamine 2,3-dioxygenase in cells (senescent and non-senescent cultures).
“Indoleamine Dioxygenase activity showed insignificant differences in cells exposed to dasatinib versus control groups”
Cellssenescent and non-senescent culturescultured-cells
Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
Cellular and molecular bioengineering
Associations
2Uric acid
upin humans1
1 study
Uric acid
upin humans1
Uric acid predicts indoleamine 2,3-dioxygenase in humans (r = 0.315, P < 0.001).
“Multiple regression analyses showed that uric acid (r = 0.315; P < 0.001) was an independent predictor of IDO activity in all subjects.”
Humansfemalesn = 140
Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndrome
Journal of diabetes and metabolic disorders
Metabolic syndrome
upin humans1
1 study
Metabolic syndrome
upin humans1
Indoleamine 2,3-dioxygenase predicts metabolic syndrome in humans (AUC = 0.646).
“IDO activity independently predicted MetS. In ROC curve analysis, TG/HDL-C demonstrated high (AUC = 0.886) and IDO activity moderate (AUC = 0.646) performance in predicting Mtes.”
Humansfemalesn = 140
Dysregulated indoleamine 2,3-dioxygenase contributes to metabolic syndrome
Journal of diabetes and metabolic disorders